Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Mannis GN"'
Autor:
Villar-Prados A; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Odabas A; Department of Medicine, Internal Medicine Residency Program, Stanford University School of Medicine, Stanford, CA., Menke JR; Department of Pathology, Stanford University, Stanford, CA., Kingham K; Department of Genetics, Stanford University, Stanford, CA., Mannis GN; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Oct; Vol. 8, pp. e2400411. Date of Electronic Publication: 2024 Oct 11.
Autor:
Brar N; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Lawrence L; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Fung E; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Zehnder JL; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US.; Department of Medicine, Division of Hematology, Cancer Institute, Stanford, CA, US., Greenberg PL; Department of Medicine, Division of Hematology, Cancer Institute, Stanford, CA, US.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, US., Mannis GN; Department of Medicine, Division of Hematology, Cancer Institute, Stanford, CA, US., Zhang TY; Department of Medicine, Division of Hematology, Cancer Institute, Stanford, CA, US.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, US., Gratzinger D; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Oak J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Silva O; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Kurzer J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Tan B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Menke JR; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US., Fernandez-Pol S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, US.
Publikováno v:
American journal of clinical pathology [Am J Clin Pathol] 2024 Sep 03; Vol. 162 (3), pp. 269-281.
Autor:
Issa GC; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Aldoss I; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Thirman MJ; Biological Sciences Division, The University of Chicago Medicine, Chicago, IL., DiPersio J; John T. Milliken Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO., Arellano M; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Blachly JS; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Mannis GN; Division of Hematology, Stanford University School of Medicine, Stanford, CA., Perl A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Dickens DS; University of Iowa Stead Family Children's Hospital, Iowa City, IA., McMahon CM; UCHealth Blood Disorders and Cell Therapies Center, University of Colorado School of Medicine, Aurora, CO., Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, and Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Grove CS; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Stone R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shami PJ; University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Mantzaris I; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY., Greenwood M; Department of Haematology, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Cuglievan B; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Kovacsovics T; City of Hope Phoenix, Goodyear, AZ., Gu Y; Syndax Pharmaceuticals, Inc, Waltham, MA., Bagley RG; Syndax Pharmaceuticals, Inc, Waltham, MA., Madigan K; Syndax Pharmaceuticals, Inc, Waltham, MA., Chudnovsky Y; Syndax Pharmaceuticals, Inc, Waltham, MA., Nguyen HV; Syndax Pharmaceuticals, Inc, Waltham, MA., McNeer N; Syndax Pharmaceuticals, Inc, Waltham, MA., Stein EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 09, pp. JCO2400826. Date of Electronic Publication: 2024 Aug 09.
Autor:
Hu X; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA., Ediriwickrema A; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA., Saleem A; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Tan B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mannis GN; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA. Electronic address: gmannis@stanford.edu.
Publikováno v:
Leukemia research [Leuk Res] 2024 Apr; Vol. 139, pp. 107479. Date of Electronic Publication: 2024 Mar 11.
Autor:
Huang LW; San Francisco VA Health Care System, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: li-wen.huang@ucsf.edu., Shi Y; San Francisco VA Health Care System, San Francisco, CA, USA; Division of Geriatrics, University of California San Francisco, San Francisco, CA, USA., Andreadis C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Logan AC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Mannis GN; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Smith CC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Gaensler KML; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Martin TG; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Damon LE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Boscardin WJ; San Francisco VA Health Care System, San Francisco, CA, USA; Division of Geriatrics, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Steinman MA; San Francisco VA Health Care System, San Francisco, CA, USA; Division of Geriatrics, University of California San Francisco, San Francisco, CA, USA., Olin RL; San Francisco VA Health Care System, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2023 Nov; Vol. 14 (8), pp. 101623. Date of Electronic Publication: 2023 Sep 06.
Autor:
Shallis RM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA., Daver N; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Altman JK; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Pollyea DA; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Badar T; Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bhatt VR; Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA., de Botton S; Gustave Roussy Cancer Center, Villejuif, France., de la Fuente Burguera A; MD Anderson Cancer Center, Madrid, Spain., Carraway HE; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Desai P; Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA., Dillon R; Department of Medical and Molecular Genetics, King's College, London, UK., Duployez N; Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France., El Chaer F; Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA., Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Gojo I; Division of Hematologic Malignancies, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Jonas BA; Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis, Davis, CA, USA., Konopleva M; Montefiore Einstein Cancer Center & Albert Einstein College of Medicine, New York, NY, USA., Lin TL; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS, USA., Mannis GN; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Mascarenhas J; Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Michaelis LC; Division of Hematology and Oncology, Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, USA., Mims AS; Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Montesinos P; Hospital Universitari I Politecnic La Fe, Valencia, Spain., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Pratz KW; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Schuh AC; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada., Sekeres MA; Division of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL, USA., Smith CC; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Stahl M; Leukemia Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Subklewe M; Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany., Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Voso MT; Department of Biomedicine and Prevention, Tor Vergata University, and Neuro-Oncohematology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia, Rome, Italy., Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Wang ES; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Zeidner JF; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Žučenka A; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania and Institute of Clinical Medicine, Vilnius, Lithuania., Zeidan AM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Sep; Vol. 10 (9), pp. e767-e776. Date of Electronic Publication: 2023 Aug 09.
Autor:
Khanna V; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Azenkot T; Department of Medicine, University of California Davis School of Medicine, Sacramento, CA, USA., Liu SQ; Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, USA., Gilbert J; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA., Cheung E; Department of Pharmacy, Stanford Healthcare, Stanford, CA, USA., Lau K; Department of Pharmacy, Stanford Healthcare, Stanford, CA, USA., Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA., Traer E; Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, USA., Jonas BA; Department of Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA, USA., Zhang TY; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Mannis GN; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: gmannis@stanford.edu.
Publikováno v:
Leukemia research [Leuk Res] 2023 Aug; Vol. 131, pp. 107331. Date of Electronic Publication: 2023 May 29.
Autor:
Tsang M; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Bischoff K; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA., Schoenbeck KL; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA., Berry K; Executive Finance Consultant, Department of Medicine, University of California San Francisco, San Francisco, CA., O'Riordan D; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA., Fakhri B; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA., Wong SW; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Shah N; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Olin R; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Andreadis C; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Vieaux J; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA., Cohen E; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA., Lopez NS; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA., Mannis GN; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA., Rabow M; Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jul 11; Vol. 7 (13), pp. 3146-3149.
Autor:
St Martin EC; Department of Medicine, Stanford University, Stanford, CA., Zhang TY; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA., Mannis GN; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA. Electronic address: gmannis@stanford.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Jun; Vol. 23 (6), pp. 410-412. Date of Electronic Publication: 2023 Apr 01.
Autor:
Hasty A; Department of Medicine Stanford University Stanford California USA., Joshi M; Department of Medicine Stanford University Stanford California USA., Lee D; Division of Hematology Stanford University Stanford California USA., Mannis GN; Division of Hematology Stanford University Stanford California USA.
Publikováno v:
EJHaem [EJHaem] 2023 Feb 27; Vol. 4 (2), pp. 497-498. Date of Electronic Publication: 2023 Feb 27 (Print Publication: 2023).